2011
DOI: 10.1258/acb.2011.011020
|View full text |Cite
|
Sign up to set email alerts
|

Doege-Potter syndrome and ‘big-IGF2’: a rare cause of hypoglycaemia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
12
0
3

Year Published

2012
2012
2023
2023

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 25 publications
(16 citation statements)
references
References 13 publications
1
12
0
3
Order By: Relevance
“…For diagnosis, it must be taken into account that IGF-2 tests tend to be normal; due to the fact that it does not exist any patented way of testing for the IGF-2 parahormone (at high levels in these cases), the increase in the IGF-2/IGF-1 ratio is used as guidance for diagnosis. This occurs because the high levels of the IGF-2 special form produced by the tumor contribute to decrease the levels of IGF-1 by negative feedback, producing an increase in the IGF-2/IGF-1 ratio [8,9].…”
Section: Discussion/conclusionmentioning
confidence: 99%
“…For diagnosis, it must be taken into account that IGF-2 tests tend to be normal; due to the fact that it does not exist any patented way of testing for the IGF-2 parahormone (at high levels in these cases), the increase in the IGF-2/IGF-1 ratio is used as guidance for diagnosis. This occurs because the high levels of the IGF-2 special form produced by the tumor contribute to decrease the levels of IGF-1 by negative feedback, producing an increase in the IGF-2/IGF-1 ratio [8,9].…”
Section: Discussion/conclusionmentioning
confidence: 99%
“…It can happen with SFTs arising in all sites. Hypoglycemia can occur due to tumor secretion of large insulin-like growth factor II (IGF2) [10]. …”
Section: Discussionmentioning
confidence: 99%
“…El SDP es poco frecuente, en la mayoría de los casos ha sido asociado a tumores fi brosos intratorácicos, aunque también se ha asociado a otro tipo de tumores intratorácicos y a tumores fi brosos extratorácicos [1][2][3][4]14 . Como factores responsables de la hipoglicemia en el SDP se han postulado varias teorías: secreción excesiva por el tumor de IGF-II (Factor de crecimiento similar a la insulina), falla en los mecanismos compensadores para prevenir la hipoglicemia y acelerado consumo de glucosa por tumores de gran tamaño 1,2,[14][15][16][17] . La hipoglicemia se ha comunicado en pacientes que presentaron concomitantemente un aumento de IGF-II.…”
Section: Discussionunclassified